Cargando…

A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth

Cripto-1 is a member of the EGF-CFC/FRL1/Cryptic family and is involved in embryonic development and carcinogenesis. We designed a novel anti-Cripto-1 artificial antibody and assessed the recognition to the antigen and the potential to suppress the growth of cancer stem cells. First, single chain an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishii, Hiroko, Zahra, Maram H., Takayanagi, Atushi, Seno, Masaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915030/ https://www.ncbi.nlm.nih.gov/pubmed/33567764 http://dx.doi.org/10.3390/ijms22041709

Ejemplares similares

Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
por: Alam, Md Jahangir, et al.
Publicado: (2018)

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
por: Ishii, Hiroko, et al.
Publicado: (2021)

Expression of cripto in Human Pancreatic Tumors
por: Tsutsumi, Masahiro, et al.
Publicado: (1994)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

Expression of cripto, a Novel Gene of the Epidermal Growth Factor Family, in Human Gastrointestinal Carcinomas
por: Kuniyasu, Hiroki, et al.
Publicado: (1991)

Autoregulation and Heterogeneity in Expression of Human Cripto-1
por: Loying, Pojul, et al.
Publicado: (2015)

The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells
por: Hassan, Ghmkin, et al.
Publicado: (2022)

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas.
por: Qi, C. F., et al.
Publicado: (1994)

New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding
por: Focà, Annalia, et al.
Publicado: (2015)

Cripto-1 as a novel therapeutic target for triple negative breast cancer
por: Castro, Nadia P., et al.
Publicado: (2014)

CRIPTO-1 Is Immunolocalized in the Syncytiotrophoblast of Ampullary Pregnancies
por: Cabar, Fábio Roberto, et al.
Publicado: (2022)

Translational significance of Nodal, Cripto-1 and Notch4 in adult nevi
por: Strizzi, Luigi, et al.
Publicado: (2016)

Expression and functional role of CRIPTO-1 in cutaneous melanoma
por: De Luca, A, et al.
Publicado: (2011)

Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
por: Wu, Zhengrong, et al.
Publicado: (2009)

Cripto haploinsufficiency affects in vivo colon tumor development
por: GIORGIO, EMILIA, et al.
Publicado: (2014)

Clinical significance of cripto-1 expression in lung adenocarcinoma
por: Zhang, Hua, et al.
Publicado: (2017)

Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
por: Nawara, Hend M., et al.
Publicado: (2021)

Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1
por: Watanabe, Kazuhide, et al.
Publicado: (2009)

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
por: Li, Xiao-shan, et al.
Publicado: (2019)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
por: Freeman, David W., et al.
Publicado: (2021)

Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer
por: Francescangeli, F, et al.
Publicado: (2015)

Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells
por: Nawara, Hend M., et al.
Publicado: (2020)

New Insights into Cancer Targeted Therapy: Nodal and Cripto-1 as Attractive Candidates
por: Arboretto, Paola, et al.
Publicado: (2021)

CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer
por: Zoni, E, et al.
Publicado: (2017)

Tumorigenic Factor CRIPTO-1 Is Immunolocalized in Extravillous Cytotrophoblast in Placenta Creta
por: Bandeira, Carla Letícia, et al.
Publicado: (2014)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Cripto-1 vaccination elicits protective immunity against metastatic melanoma
por: Ligtenberg, M. A., et al.
Publicado: (2016)

Exosomal Cripto-1 Serves as a Potential Biomarker for Perihilar Cholangiocarcinoma
por: Hu, Chunxiao, et al.
Publicado: (2021)

Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency
por: Fiorenzano, Alessandro, et al.
Publicado: (2016)

Cancer stem cells induced by chronic stimulation with prostaglandin E2 exhibited constitutively activated PI3K axis
por: Minematsu, Hideki, et al.
Publicado: (2022)

A Novel Localization in Human Large Extracellular Vesicles for the EGF-CFC Founder Member CRIPTO and Its Biological and Therapeutic Implications
por: Mantile, Francesca, et al.
Publicado: (2022)

Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways
por: Hu, X F, et al.
Publicado: (2007)

Elevated serum Cripto‐1 and VEGF levels in patients with non‐small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2022)

Conditional Cripto overexpression in satellite cells promotes myogenic commitment and enhances early regeneration
por: Prezioso, Carolina, et al.
Publicado: (2015)

Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells
por: Huang, Chun, et al.
Publicado: (2015)

Cripto shapes macrophage plasticity and restricts EndMT in injured and diseased skeletal muscle
por: Iavarone, Francescopaolo, et al.
Publicado: (2020)

In vivo and in vitro study of co-expression of LMP1 and Cripto-1 in nasopharyngeal carcinoma()
por: Ye, Qing, et al.
Publicado: (2019)

Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways
por: Hassan, Ghmkin, et al.
Publicado: (2022)

GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation
por: Hassan, Ghmkin, et al.
Publicado: (2023)

A novel model of liver cancer stem cells developed from induced pluripotent stem cells
por: Afify, Said M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u61ju374jtsadqe5juv7eiie5g